share_log

Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)

Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)

Eterna Therapeutics Inc於3月19日收到納斯達克的通知，稱該公司不遵守納斯達克上市規則5550 (B) (1)
Benzinga ·  03/23 04:37

Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)

Eterna Therapeutics Inc於3月19日收到納斯達克的通知，稱該公司不遵守納斯達克上市規則5550 (B) (1)

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論